Author:
Shahin Hady,Elmasry Moustafa,Steinvall Ingrid,Markland Katrin,Blomberg Pontus,Sjöberg Folke,El-Serafi Ahmed T.
Abstract
AbstractThe rules governing Medicinal Products in the European Union necessitates the production of cell-based therapy in good manufacturing practice facilities. The produced cells may need several hours in transportation to reach the application sites. In this study, we investigated four candidate solutions for transporting human keratinocytes. The solutions are (1) normal saline, (2) saline with 2.5% human serum albumin (Saline + HSA), (3) chemically defined, xeno-free keratinocyte media and (4) keratinocyte media with pituitary bovine extract (PBE-media). One million keratinocytes from three donors were suspended in each solution and kept at 4 °C for up to 24 h. Cells kept in Saline + HSA showed higher viability after 1, 3 and 24 h. Then, equal number of viable cells were seeded on collagenous matrix and cultured for 48 h. The adhesion and colonization were higher in the cells kept in PBE-media, while the keratinocyte surface marker, cytokeratin 14, was present in all studied groups. These results confirmed the suitability of Saline + HSA as a cell transportation solution for clinical use, which will be the choice for the planned clinical trial. Keratinocyte PBE-media can be an alternative for cells transported for research purpose, if the same media type is going to be used in the following experiments.
Funder
Linköping University Library
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Li, Z. & Maitz, P. Cell therapy for severe burn wound healing. Burns Trauma 6, 13. https://doi.org/10.1186/s41038-018-0117-0 (2018).
2. Fang, T., Lineaweaver, W. C., Sailes, F. C., Kisner, C. & Zhang, F. Clinical application of cultured epithelial autografts on acellular dermal matrices in the treatment of extended burn injuries. Ann. Plast. Surg. 73, 509–515. https://doi.org/10.1097/SAP.0b013e3182840883 (2014).
3. Gardien, K. L. et al. Outcome of burns treated with autologous cultured proliferating epidermal cells: A prospective randomized multicenter intrapatient comparative trial. Cell Transpl. 25, 437–448. https://doi.org/10.3727/096368915X689569 (2016).
4. Iglesias-López, C., Agustí, A., Obach, M. & Vallano, A. Regulatory framework for advanced therapy medicinal products in Europe and United States. Front. Pharmacol. https://doi.org/10.3389/fphar.2019.00921 (2019).
5. López-Fraga, M. & Lomero, M. Guide to the Quality and Safety of Tissues and Cells for Human Application 3rd edn. (eds. López-Fraga, M. & Lomero, M.) 109–111 (EQDM, 2017).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献